Volume 69 Received 3 December 2012 | ||||||||||
| ||||||||||
aDepartment of Physics, Presidency College, Chennai 600 005, India, and bDepartment of Organic Chemistry, University of Madras, Guindy Campus, Chennai 600 025, India
Correspondence e-mail: aravindhanpresidency@gmail.com
In the title compound, C23H20N2O6, the fused pyrone and pyran rings each adopt a sofa conformation. The dihedral angle between the mean planes of the pyran and phenyl rings is 61.9 (1)°. In the crystal, molecules are linked by two pairs of C-H
O hydrogen bonds, forming dimers. These dimers are linked via a third C-H
O hydrogen bond, forming a two-dimensional network parallel to (10-2).
For the biological activity of pyranocoumarin compounds, see: Kawaii et al. (2001
); Hossain et al. (1996
); Goel et al. (1997
); Su et al. (2009
); Xu et al. (2006
). For anti-filarial activity studies, see: Casley-Smith et al. (1993
). For their enzyme inhibitory activity, see: Pavao et al. (2002
). For asymmetry parameters, see: Nardelli (1983
).
|
|
| |||||||||||||||||||||||||||
Data collection: APEX2 (Bruker, 2004
); cell refinement: APEX2 and SAINT (Bruker, 2004
); data reduction: SAINT and XPREP (Bruker, 2004
); program(s) used to solve structure: SHELXS97 (Sheldrick, 2008
); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008
); molecular graphics: ORTEP-3 for Windows (Farrugia, 2012
); software used to prepare material for publication: PLATON (Spek, 2009
).
Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: SU2537 ).
SA thanks the UGC, India, for financial support
Bruker (2004). APEX2, SAINT, XPREP and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Casley-Smith, J. R., Wang, C. T., Casley-Smith, J. R. & Zi-hai, C. (1993). Br. Med. J. 307, 1037-1041. ![[ChemPort]](../../../../../../logos/chemportborder.gif)
Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849-854.
![[details]](../../../../../../j/graphics/details.gif)
Goel, R. K., Maiti, R. N., Manickam, M. & Ray, A. B. (1997). Indian J. Exp. Biol. 35, 1080-1083.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Hossain, C. F., Okuyama, E. & Yamazaki, M. (1996). Chem. Pharm. Bull. (Tokyo), 44, 1535-1539.
![[PubMed]](../../../../../../logos/pubmedborder.gif)
Kawaii, S., Tomono, Y., Ogawa, K., Sugiura, M., Yano, M., Yoshizawa, Y., Ito, C. & Furukawa, H. (2001). Anticancer Res. 21, 1905-1911.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Nardelli, M. (1983). Acta Cryst. C39, 1141-1142.
![[details]](../../../../../../c/graphics/details.gif)
Pavao, F., Castilho, M. S., Pupo, M. T., Dias, R. L. A., Correa, A. G., Fernandes, J. B., Da Silva, M. F. G. F., Mafezoli, J., Vieir, P. C. & Oliva, G. (2002). FEBS Lett. 520, 13-17.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.
![[details]](../../../../../../a/graphics/details.gif)
Spek, A. L. (2009). Acta Cryst. D65, 148-155.
![[details]](../../../../../../d/graphics/details.gif)
Su, C. R., Yeh, S. F., Liu, C. M., Damu, A. G., Kuo, T. H., Chiang, P. C., Bastow, K. F., Lee, K. H. & Wu, T. S. (2009). Bioorg. Med. Chem. 17, 6137-6143.
![[ChemPort]](../../../../../../logos/chemportborder.gif)
Xu, Z. Q., Pupek, K., Suling, W. J., Enache, L. & Flavin, M. T. (2006). Bioorg. Med. Chem. 14, 4610-4626.
![[ChemPort]](../../../../../../logos/chemportborder.gif)